On September 21, 2023, the Turkish Medicines and Medical Devices Agency (TİTCK) has been listed among the national pharmaceutical authorities recognized by the World Health Organization (WHO).
With this development, it has been affirmed that all regulatory and supervisory activities concerning medicines and vaccines in Turkey adhere to WHO criteria and demonstrate the presence of a stable, well-functioning, and integrated system.
Furthermore, this recognition underscores the effective, safe, and high-quality introduction of pharmaceuticals and vaccines to the market in Turkey, once again validating the meticulous oversight. It also paves the way for Turkish-produced vaccines to be included in the product lists approved by the World Health Organization, including the prequalification/emergency use listing.
TİTCK’s acceptance into the Pharmaceutical Inspection Cooperation Scheme (PIC/s) in 2018, alongside countries such as Switzerland, the United States, the United Kingdom, Ireland, Germany, Canada, Japan, and Australia, marked a significant milestone.
In 2020, as a full member of the International Council for Harmonisation (ICH), Turkey’s Medicines and Medical Devices Agency secured its position among internationally recognized authorities in pharmaceutical licensing, clinical research, and pharmacovigilance activities.
Through our memberships that enhance the international reputation and credibility of the Turkish pharmaceutical sector, we ensure that our citizens have access to high-quality, effective, and safe medicines in line with global standards, contributing to the advancement of international trade in the field of healthcare.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
